Literature DB >> 12791310

The role of interleukin 10 in the control of autoimmunity.

Maria-Grazia Roncarolo1, Manuela Battaglia, Silvia Gregori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791310     DOI: 10.1016/s0896-8411(03)00047-7

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


× No keyword cloud information.
  11 in total

1.  APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.

Authors:  Norailys Lorenzo; Fiorella Altruda; Lorenzo Silengo; Maria Del Carmen Dominguez
Journal:  Clin Exp Med       Date:  2016-05-09       Impact factor: 3.984

Review 2.  Immune regulation during allergic bronchopulmonary mycosis: lessons taught by two fungi.

Authors:  Shikha Arora; Gary B Huffnagle
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine.

Authors:  Natalia Vapniarsky; Boaz Arzi; Jerry C Hu; Jan A Nolta; Kyriacos A Athanasiou
Journal:  Stem Cells Transl Med       Date:  2015-08-07       Impact factor: 6.940

Review 4.  Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.

Authors:  Mohammad Haque; Jugal Kishore Das; Xiaofang Xiong; Jianxun Song
Journal:  Curr Diab Rep       Date:  2019-08-30       Impact factor: 4.810

5.  APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis model.

Authors:  Norailys Lorenzo; Dolores Cantera; Ariana Barberá; Amaris Alonso; Elsy Chall; Lourdes Franco; Julio Ancizar; Yanetsy Nuñez; Fiorella Altruda; Lorenzo Silengo; Gabriel Padrón; Maria Del Carmen Dominguez
Journal:  Clin Exp Med       Date:  2014-01-29       Impact factor: 3.984

6.  The relationship of T helper-2 pathway components interleukin-4, interleukin-10, immunoglobulin e, and eosinophils with prognostic markers in non-hodgkin lymphoma: a case-control study.

Authors:  Nil Güler; Engin Kelkitli; Hilmi Atay; Dilek Erdem; Hasan Alaçam; Yüksel Bek; Düzgün Özatlı; Mehmet Turgut; Levent Yıldız; İdris Yücel
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

7.  Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant.

Authors:  Nicola Gagliani; Tatiana Jofra; Angela Stabilini; Andrea Valle; Mark Atkinson; Maria-Grazia Roncarolo; Manuela Battaglia
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

8.  Association between Interleukin-10 Gene Promoter Haplotype and Schizophrenia in a Han-Chinese Study.

Authors:  Hsin-Yi Peng; Yu-Chi Ku; Bih-Ching Shu; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-09

9.  Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice.

Authors:  Yong Zhao; Brian Lin; Robert Darflinger; Yongkang Zhang; Mark J Holterman; Randal A Skidgel
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

10.  A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases.

Authors:  Ricardo Palacios; Joaquin Goni; Ivan Martinez-Forero; Jaime Iranzo; Jorge Sepulcre; Ignacio Melero; Pablo Villoslada
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.